UnicoCell

  • About
  • Cell Therapy
  • Products & services
  • News
  • Contact
  • 中文 / EN

News

  • 2025.12.22 UnicoCell Advances to Global Stage with Phase III Clinical Trial Application for Chronic Kidney Disease Submitted to the U.S. FDA
  • 2025.12.02 UnicoCell's Real-World Data Study on Chronic Kidney Disease Published in International Journal
  • 2025.11.12 UnicoCell Biomed Co., Ltd. Completes Patient Enrollment in Phase III Clinical Trial of ELIXCYTE® for Knee Osteoarthritis
  • 2025.10.16 Unicocell Biomed Lists on General Board Poised to Seize Regenerative Medicine Opportunities with Integrated Value Chain
  • 2025.09.22 Unicocell Accelerates Regenerative Medicine Strategy with Three Core Pillars
  • 2025.08.28 UnicoCell Partners with New Cell Bio to Enter Korean’s Regenerative Medicine Market

Products & services
  • Conditioned Medium
    Conditioned Medium
    MORE
  • Mass Production and CDMO
    Mass Production and CDMO
    MORE
  • Autologous Stem Cell Therapy
    Autologous Stem Cell Therapy
    MORE
  • Allogeneic Adipose Stem Cell Bank
    Allogeneic Adipose Stem Cell Bank
    MORE
向榮生醫科技

11494 台北市內湖區民權東路六段13之20號5樓

Tel:886-2-2792-2699 FAX:886-2-2792-7890

E-Mail : info@unicocell.com

LinkedIn Facebook Line
Copyright © 2018-2026 向榮生醫科技股份有限公司